Myricx Bio is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2022.

When did Sofinnova Partners acquire Myricx Bio?

Sofinnova Partners acquired Myricx Bio in 2022 (active for 4 years).

Home/Companies/Biotech/Myricx Bio

Myricx Bio

Biotech·

UK·Active·4yr hold

Myricx Bio is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

UK drug discovery company developing small molecule NMT inhibitors for cancer, based on proprietary myristoylation biology.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings